Back
Speaker illustration

Doctor Chiara Caselli

CNR – National Research Council, Pisa (Italy)

Member of:

European Society of Cardiology

Chiara Caselli, PhD, is a Senior Researcher at Institute of Clinical Physiology (IFC-CNR). Her research is committed to elucidating the molecular causes of cardiovascular diseases (CVD). As PI or co-Investigator on National- and European-funded grants, Dr. Caselli laid the groundwork for research expertise by elucidating the molecular mechanism of cardiometabolic markers using animal models or in vitro studies, and by establishing their relation with the clinical setting.

Presentations

Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment

Event: ESC Congress 2025

Topic: Inflammation and Immunity

Session: Lipid-lowering and inflammation

Access
Like
Thumbnail

A specific molecular signature of extra-vesicles (EVs) was associated with cardiometabolic risk profile and atherosclerotic burden in patients with chronic coronary syndrome: a pilot study.

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Bench to bedside in acute coronary syndromes: from infarction size in animal studies to long-term development of chronic coronary syndrome

Access
Like
Thumbnail

Association of serum MMP9 with adverse features of plaque progression in patients with chronic coronary syndrome (CCS).

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Lesion characteristics in coronary artery disease

Access
Like
Thumbnail

Differential association of high-sensitive cardiac Troponin T and Troponin I with coronary atherosclerotic burden, inducible ischemia and long-term prognosis in patients with chronic coronary syndrome

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Chronic ischaemia

Access
Like
Thumbnail

Association of eNOS Glu298Asp polymorphism with cardiometabolic risk and inducible myocardial ischemia in patients with stable coronary artery disease

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Chronic ischaemia

Access
Like
Thumbnail

Elevated triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina.

Event: ICNC-CT 2021

Topic: Plaque Imaging

Session: e-Posters

Access
Like
Thumbnail

Elevated TG/HDL-C ratio is an independent predictor of outcome and it is associated with CAD progression in patients with stable coronary artery disease.

Event: ESC Congress 2020

Topic: Clinical

Session: Coronary Artery Disease (Chronic) ePosters

Access
Like
Thumbnail

Low PCSK9 plasma level is an independent predictor of coronary atherosclerotic burden in patients with stable coronary artery disease

Event: ESC Congress 2019

Topic: Plaque Imaging

Session: Imaging the coronaries and plaques with Computed Tomography

Access
Like
Thumbnail

Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study

Event: ESC Congress 2019

Topic: Plaque Imaging

Session: Imaging the coronaries and plaques with Computed Tomography

Access
Like
Thumbnail

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

Event: ESC Congress 2019

Topic: Lipids

Session: Lipids

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources